Engineering the Future of ADCs: Innovation, Efficacy, and Clinical Integration

Victor Jeffrey Leyton
Associate Professor
School of Pharmaceutical Sciences, Department of Cellular and Molecular Medicine at the University of Ottawa

Sophia N. Karagiannis
Professor of Translational Cancer Immunology and Immunotherapy
St. John’s Institute of Dermatology, School of Basic & Medical Biosciences, King’s College London

Sharsti Sandall
Executive Director, Head of ADC Biology
Pfizer

Stuart Barnscher
Senior Director, Preclinical Programs, ADC Therapeutic Development
Zymeworks
Format: 1 hour webinar: 20 minute interview followed by 40 minute panel discussion
Register free to attend thought leadership
Do you have a question you’d like Victor Jeffrey Leyton, Sophia N. Karagiannis, Sharsti Sandall, Stuart Barnscher to answer during the session?
Register and askRegister for free to view
-
Quickly grasp the key takeaways from cutting-edge biomed research with our bite-sized 5-minute video summaries, before diving into the full presentations from leaders in the industry.
-
From cutting-edge discoveries to real-world applications, see how new research can impact your work, from the lab to commercialisation.
-
Join a community of next-gen scientists, academics and researchers, stay connected, and engage with the latest innovations shaping the future of biomedicine.
Already registered? Sign In.